Switch theme
Sign up to access all valuation multiples
Organo Corp is a Japan-based company mainly engaged in the water treatment engineering business. The company operates in two business divisions namely water treatment engineering and functional product. Its water treatment engineering business includes manufacturing, delivery and maintenance of pure water systems, ultra-pure water systems and wastewater treatment systems for industries, condensate de mineralizers for power stations, waterworks and sewage treatment systems for the public sector. The functional product business encompasses the sale of standardized water treatment equipment, water treatment chemicals, and food processing materials.
1941
2.2K+
LTM Revenue $1.1B
LTM EBITDA $246M
$2.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Organo has a last 12-month revenue (LTM) of $1.1B and a last 12-month EBITDA of $246M.
In the most recent fiscal year, Organo achieved revenue of $1.0B and an EBITDA of $178M.
Organo expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Organo valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | XXX | $1.0B | XXX | XXX | XXX |
| Gross Profit | $386M | XXX | $301M | XXX | XXX | XXX |
| Gross Margin | 34% | XXX | 29% | XXX | XXX | XXX |
| EBITDA | $246M | XXX | $178M | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 17% | XXX | XXX | XXX |
| EBIT | $216M | XXX | $155M | XXX | XXX | XXX |
| EBIT Margin | 19% | XXX | 15% | XXX | XXX | XXX |
| Net Profit | $166M | XXX | $119M | XXX | XXX | XXX |
| Net Margin | 15% | XXX | 12% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $129M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Organo's stock price is JPY 7770 (or $53).
Organo has current market cap of JPY 357B (or $2.5B), and EV of JPY 327B (or $2.2B).
See Organo trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.2B | $2.5B | XXX | XXX | XXX | XXX | $3.62 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Organo has market cap of $2.5B and EV of $2.2B.
Organo's trades at 2.2x EV/Revenue multiple, and 13.7x EV/EBITDA.
Equity research analysts estimate Organo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Organo has a P/E ratio of 14.7x.
See valuation multiples for Organo and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.5B | XXX | $2.5B | XXX | XXX | XXX |
| EV (current) | $2.2B | XXX | $2.2B | XXX | XXX | XXX |
| EV/Revenue | 2.0x | XXX | 2.2x | XXX | XXX | XXX |
| EV/EBITDA | 9.1x | XXX | 13.7x | XXX | XXX | XXX |
| EV/EBIT | 10.4x | XXX | 15.8x | XXX | XXX | XXX |
| EV/Gross Profit | 5.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 14.7x | XXX | 22.4x | XXX | XXX | XXX |
| EV/FCF | 18.1x | XXX | -95.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialOrgano's last 12 month revenue growth is 9%
Organo's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.
Organo's rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Organo's rule of X is 43% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Organo and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | 2% | XXX | 27% | XXX | XXX | XXX |
| Rule of 40 | 25% | XXX | 25% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 43% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 14% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| TAQA | XXX | XXX | XXX | XXX | XXX | XXX |
| New Sources Energy | XXX | XXX | XXX | XXX | XXX | XXX |
| AGL Energy | XXX | XXX | XXX | XXX | XXX | XXX |
| APA Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Chrysos Corp. | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Organo acquired XXX companies to date.
Last acquisition by Organo was XXXXXXXX, XXXXX XXXXX XXXXXX . Organo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Organo founded? | Organo was founded in 1941. |
| Where is Organo headquartered? | Organo is headquartered in Japan. |
| How many employees does Organo have? | As of today, Organo has 2.2K+ employees. |
| Is Organo publicy listed? | Yes, Organo is a public company listed on TKS. |
| What is the stock symbol of Organo? | Organo trades under 6368 ticker. |
| When did Organo go public? | Organo went public in 1961. |
| Who are competitors of Organo? | Similar companies to Organo include e.g. TAQA, New Sources Energy, AGL Energy, APA Group. |
| What is the current market cap of Organo? | Organo's current market cap is $2.5B |
| What is the current revenue of Organo? | Organo's last 12 months revenue is $1.1B. |
| What is the current revenue growth of Organo? | Organo revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Organo? | Current revenue multiple of Organo is 2.0x. |
| Is Organo profitable? | Yes, Organo is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Organo? | Organo's last 12 months EBITDA is $246M. |
| What is Organo's EBITDA margin? | Organo's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of Organo? | Current EBITDA multiple of Organo is 9.1x. |
| What is the current FCF of Organo? | Organo's last 12 months FCF is $124M. |
| What is Organo's FCF margin? | Organo's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Organo? | Current FCF multiple of Organo is 18.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
